Cynosure Lutronic, a global developer of energy-based aesthetic technologies, announces the launch of XERF, its next-generation monopolar radiofrequency (RF) skin-tightening platform, in Europe.
Designed to deliver two frequencies—6.78 MHz and 2 MHz—within a single treatment shot, XERF enables RF energy to penetrate multiple tissue depths simultaneously and address superficial, mid-dermal, and deeper structural layers within the same session, providing visible, natural-looking results without needles, numbing, or downtime. Since its initial launch in Korea, XERF was adopted by practitioners in both South Korea and the US.
The launch follows a consumer survey of more than 4,700 adults across Europe and Saudi Arabia commissioned by Cynosure Lutronic and conducted by independent research firm Appinio. According to the survey, 58% of respondents rated firming sagging skin as very or extremely important, and 67% expressed a preference for treatments that do not require needles. In addition, 28.3% of respondents cited “clear evidence of long-lasting results” as a factor that would motivate undecided patients to consider a non-surgical skin-tightening treatment.
Engineered in Korea, XERF features:
Dual frequencies (6.78 MHz and 2 MHz): Combining two frequencies in a single shot enables simultaneous treatment across multiple tissue depths.
Three depth settings and 10 energy levels: Gives clinicians the flexibility to personalize every treatment.
WaveFit Pulse technology: Distributes RF energy across multiple pulses rather than concentrating it in short, high-intensity bursts, producing a more controlled rise in tissue temperature.
Advanced Integrated Cryogen Delivery (ICD) cooling: Continuously protects the skin’s surface throughout treatment, maintaining the epidermis at a safe temperature while energy is delivered to the layers beneath.
These technologies are designed to reduce the need for pre-treatment numbing for many patients.
“XERF has earned an outstanding reputation in the United States and across the Asia-Pacific region, where it has been adopted by leading practitioners,” says Nikhil Nathwani, Vice President for EMEA at Cynosure Lutronic, in a news release.
“Data tells us people are not simply looking for treatments that make them look younger. They want to invest in the long-term health of their skin, and they want results they can trust to last,” Nathwani adds. “We’re proud to make XERF available to clinicians who are ready to deliver a genuinely differentiated treatment experience.”
